Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two leading scientists from the University of Oxford will join Professor Jonathan Van-Tam at this year’s Christmas Lectures by the Royal Institution.

Professors Teresa Lambe OBE and Katie Ewer © John Cairns

Professors Teresa Lambe OBE and Katie Ewer, who both played a key role in the UK’s response to the ongoing COVID-19 pandemic, will lead an on-screen exploration into their areas of scientific expertise.

They will aim to offer insights into the world of viruses – how they infect humans, and how humans respond – particularly in the context of vaccine development and infection control. They will also reveal why discoveries and advances made during the ongoing pandemic will have an impact far beyond COVID-19 and are set to change the future of medicine.

Prof Lambe is one of the Principal Investigators at the University of Oxford, overseeing the Oxford-AstraZeneca vaccine programme. From January 2020, she co-designed the vaccine, led the pre-clinical studies and then oversaw the delivery of the immune results needed to support regulatory approval of the vaccine in late 2020.

She said: ‘The Christmas Lectures are such a unique opportunity to share a passion for science, and to encourage young people to stay in science and to stay inquisitive. We need this enthusiasm, now more than ever, to tackle the big questions facing society.’

Professor Ewer is a cellular immunologist and Associate Professor at the Jenner Institute at the University of Oxford. During the pandemic, she has been an investigator on clinical trials of the Oxford/AZ vaccine, studying samples from volunteers to determine the strength of their cellular immune response to vaccination and how those responses relate to protection against COVID-19 infection.

Read the full story on the University of Oxford website

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.